Ideagen PLC

("Ideagen," "the Company" or the "Group'')

PDMR dealing, exercise of options and total voting rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has received notification for the exercise of Options, including by directors of the Company and a number of other Persons Discharging Managerial Responsibilities ("PDMR"), over 2,100,000 ordinary shares of 1 pence each ("Ordinary Shares") which are being satisfied by the issue of 2,100,000 new Ordinary Shares.

Subsequently, 1,050,000 Ordinary Shares were sold to cover the taxes associated with the exercise of these options. The Options exercised relate to the Company's 2018 LTIP scheme. The Board (other than those exercising their Options) used its discretion under the rules of the LTIP share option schemes to allow the early exercise of the options. However, other than the sales of shares to cover the taxes, the rules of the LTIP share option schemes require that the remaining shares issued pursuant to this exercise cannot be sold before the fourth anniversary of the original option grant date.

Details of all PDMR dealings are included in the below table.

Following the above transactions, Ben Dorks holds 2,953,216 Ordinary Shares (representing 1.2% of the Company's issued Ordinary Shares) and Emma Hayes holds 281,250 Ordinary Shares (representing 0.1% of the Company's issued Ordinary Shares). The Company has 1,737,147 options in issue.

Application has been made to the London Stock Exchange for the 2,100,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on or around 29 July 2021.

After Admission, the total number of Ordinary Shares in issue will be 254,460,322 and the total number of voting rights will therefore be 254,460,322. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310

Enquiries:

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

A global supplier of regulatory and compliance solutions, Ideagen provides a common software platform and an integrated risk-based approach to meet multi-industry standards, enabling compliance with relevant laws, policies, and regulations.

The Group provides software and services to organisations operating within highly regulated industries such as life sciences, healthcare, banking and finance, insurance, aviation, and aerospace and defence, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

Currently, over 6,000 organisations use Ideagen's products including nine of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 250 hospitals across the UK and US amongst its client base. For further information please visit www.ideagen.com .